Abstract

The Task Force Report from the Foundation for Managed Care Pharmacy (FMCP) in this issue of the journal [1] offers an overview of the welcome update of the Academy of Managed Care Pharmacy (AMCP) Format for Formulary Submissions (Version 2.0), which was published in October 2002 (available from http://www.fmcpnet.org). Reflecting on the experience with the first AMCP Format, the report echoes many issues that will be familiar to those developing guidance for clinical and economic evidence reimbursement submissions around the world. The challenge is how to get relevant and rigorous evidence to managed care formulary decision makers while navigating the regulatory and commercial realities of the pharmaceutical marketplace.